(Q36079645)

12 August 2017

Tamoxifen delays the development of resistance to cisplatin in human melanoma and ovarian cancer cell lines (English)

1 reference

12 August 2017

1 reference

1 reference

1 reference

E F McClay

1

1 reference

12 August 2017

K D Albright

2

1 reference

12 August 2017

J A Jones

3

1 reference

12 August 2017

R D Christen

4

1 reference

12 August 2017

S B Howell

5

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 September 1994

1 reference

British Journal of Cancer

12 August 2017

1 reference

12 August 2017

70

1 reference

12 August 2017

449-452

1 reference

12 August 2017

3

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1994.326

12 August 2017

0 references

cites work

The pharmacology and clinical uses of tamoxifen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033375

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033375

Combination chemotherapy and hormonal therapy in the treatment of malignant melanoma

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033375

Cellular pharmacology of cisplatin: perspectives on mechanisms of acquired resistance

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033375

Tamoxifen modulation of cisplatin sensitivity in human malignant melanoma cells

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033375

Tamoxifen modulation of cisplatin resistance in patients with metastatic melanoma. A biologically important observation

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033375

Tamoxifen modulation of cisplatin cytotoxicity in human malignancies

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033375

cis-Diamminedichloroplatinum(II) accumulation in sensitive and resistant human ovarian carcinoma cells.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033375

The importance of tamoxifen to a cisplatin-containing regimen in the treatment of metastatic melanoma

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033375

Reversal of acquired resistance to adriamycin in CHO cells by tamoxifen and 4-hydroxy tamoxifen: role of drug interaction with alpha 1 acid glycoprotein

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033375

Induction of covalent DNA adducts in rodents by tamoxifen.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033375

Effective combination chemo/hormonal therapy for malignant melanoma: experience with three consecutive trials

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033375

Modulation of cisplatin resistance in human malignant melanoma cells

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033375

Use of nude mouse xenografts as preclinical screens. Characterization of xenograft-derived melanoma cell lines.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033375

Correlation of in vitro drug-sensitivity testing results with response to chemotherapy and survival in extensive-stage small cell lung cancer: a prospective clinical trial

23 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/8080729

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/BJC.1994.326

1 reference

12 August 2017

1 reference

12 August 2017

1 reference